230 related articles for article (PubMed ID: 21611151)
1. Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells.
He S; Kato K; Jiang J; Wahl DR; Mineishi S; Fisher EM; Murasko DM; Glick GD; Zhang Y
PLoS One; 2011; 6(5):e20107. PubMed ID: 21611151
[TBL] [Abstract][Full Text] [Related]
2. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity.
Li Q; Rao R; Vazzana J; Goedegebuure P; Odunsi K; Gillanders W; Shrikant PA
J Immunol; 2012 Apr; 188(7):3080-7. PubMed ID: 22379028
[TBL] [Abstract][Full Text] [Related]
3. The Energy Sensor AMPKα1 Is Critical in Rapamycin-Inhibition of mTORC1-S6K-Induced T-cell Memory.
Ara A; Xu A; Ahmed KA; Leary SC; Islam MF; Wu Z; Chibbar R; Xiang J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008461
[TBL] [Abstract][Full Text] [Related]
4. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
[TBL] [Abstract][Full Text] [Related]
5. mTOR regulates memory CD8 T-cell differentiation.
Araki K; Turner AP; Shaffer VO; Gangappa S; Keller SA; Bachmann MF; Larsen CP; Ahmed R
Nature; 2009 Jul; 460(7251):108-12. PubMed ID: 19543266
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma.
Kittipongdaja W; Wu X; Garner J; Liu X; Komas SM; Hwang ST; Schieke SM
J Invest Dermatol; 2015 Sep; 135(9):2301-2308. PubMed ID: 25897830
[TBL] [Abstract][Full Text] [Related]
7. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
9. Modulation of asymmetric cell division as a mechanism to boost CD8
Borsa M; Barnstorf I; Baumann NS; Pallmer K; Yermanos A; Gräbnitz F; Barandun N; Hausmann A; Sandu I; Barral Y; Oxenius A
Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 30979796
[TBL] [Abstract][Full Text] [Related]
10. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
11. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
[TBL] [Abstract][Full Text] [Related]
12. Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.
Ezzelarab MB; Lu L; Guo H; Zahorchak AF; Shufesky WF; Cooper DK; Morelli AE; Thomson AW
Transplantation; 2016 Jan; 100(1):91-102. PubMed ID: 26680373
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.
Sukumar M; Liu J; Ji Y; Subramanian M; Crompton JG; Yu Z; Roychoudhuri R; Palmer DC; Muranski P; Karoly ED; Mohney RP; Klebanoff CA; Lal A; Finkel T; Restifo NP; Gattinoni L
J Clin Invest; 2013 Oct; 123(10):4479-88. PubMed ID: 24091329
[TBL] [Abstract][Full Text] [Related]
14. Lack of Sprouty 1 and 2 enhances survival of effector CD8
Shehata HM; Khan S; Chen E; Fields PE; Flavell RA; Sanjabi S
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8939-E8947. PubMed ID: 30126987
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid imprints a low glucose metabolism onto CD8 T cells and induces the persistent suppression of the immune response.
Konishi A; Suzuki J; Kuwahara M; Matsumoto A; Nomura S; Soga T; Yorozuya T; Yamashita M
Biochem Biophys Res Commun; 2022 Jan; 588():34-40. PubMed ID: 34942532
[TBL] [Abstract][Full Text] [Related]
16. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development.
O'Sullivan D; van der Windt GJ; Huang SC; Curtis JD; Chang CH; Buck MD; Qiu J; Smith AM; Lam WY; DiPlato LM; Hsu FF; Birnbaum MJ; Pearce EJ; Pearce EL
Immunity; 2014 Jul; 41(1):75-88. PubMed ID: 25001241
[TBL] [Abstract][Full Text] [Related]
17. Enhancing CD8 T-cell memory by modulating fatty acid metabolism.
Pearce EL; Walsh MC; Cejas PJ; Harms GM; Shen H; Wang LS; Jones RG; Choi Y
Nature; 2009 Jul; 460(7251):103-7. PubMed ID: 19494812
[TBL] [Abstract][Full Text] [Related]
18. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
[TBL] [Abstract][Full Text] [Related]
19. Immunology: A metabolic switch to memory.
Prlic M; Bevan MJ
Nature; 2009 Jul; 460(7251):41-2. PubMed ID: 19571872
[No Abstract] [Full Text] [Related]
20. Constitutive Glycolytic Metabolism Supports CD8
Phan AT; Doedens AL; Palazon A; Tyrakis PA; Cheung KP; Johnson RS; Goldrath AW
Immunity; 2016 Nov; 45(5):1024-1037. PubMed ID: 27836431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
